Testing a new device for continuous glucose and ketone monitoring in healthy individuals

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study aims to validate and test a novel device designed for continuous monitoring of glucose and ketone levels in healthy volunteers. It addresses the challenges faced by individuals with type 1 diabetes in managing diabetic ketoacidosis, a serious complication that arises from high glucose and ketone levels. The device is minimally invasive and seeks to improve upon current methods that rely on single time point measurements through blood or urine strips. By providing continuous data, the device could enhance the management of diabetes and potentially prevent severe complications.

Why it matters

Who can join: the full rules

The age range for the healthy volunteers (HVs) will be between 18 and 45 years old and with no family history of Diabetes (T1D or T2D, specifically biological parents and siblings).

Exclusion criteria included: (i) currently taking any medications (except for birth control for females); (ii) following a low-carbohydrate diet or consuming nutritional ketone supplements; (iii) considered competitive athlete engaged in competition or intensive training, (iv) have been diagnosed with Diabetes (T1D or T2D), hypertension, cardiovascular disease, kidney disease, and thyroid disorder. (v) Having an allergy to any of the ingredients in the products used in the study, which will be explained to you in detail.

Where it's running

• University of Waterloo
  Waterloo, Ontario, Canada Recruiting

Study contacts

• Study coordinator: Mahla Poudineh
• Email: mahla.poudineh@uwaterloo.ca
• Phone: 5198884567

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Perfusion index in the emergency department to gauge DKA severity

  This study tests whether the perfusion index measured at ED admission can help predict how severe diabetic ketoacidosis will be in adults.

  Recruiting Ankara Etlik City Hospital · Ankara, Ankara and 1 other locations · NCT07820371

• Markers of early kidney and heart injury in children newly diagnosed with type 1 diabetes

  This study will test whether blood markers and heart ultrasound can find early kidney or heart injury in children aged 2–16 who are newly diagnosed with type 1 diabetes, comparing those with diabetic ketoacidosis, those without, and healthy children.

  Recruiting Aristotle University Of Thessaloniki · Thessaloniki, Central Makedonia · NCT07483879

• Recognizing dapagliflozin overdose in ICU patients admitted for metformin poisoning.

  This project will see if clinical signs and routine lab tests can help doctors tell whether adults in the ICU for metformin poisoning also took too much dapagliflozin.

  Recruiting Centre Hospitalier de Saint-Denis · Saint-Denis, France · NCT07193069

• Intravenous arginine to help treat diabetic ketoacidosis in people with type 2 diabetes

  This study tests whether a single IV dose of arginine given early in DKA can safely boost your own insulin and help adults with ketone-prone type 2 diabetes recover faster.

  Recruiting Phase 1/2 Wayne State University · Detroit, Michigan · NCT07167693

• Using REAMBERIN® for treating diabetic ketoacidosis

  This study is testing if adding a new treatment called REAMBERIN® to standard care can help people with diabetic ketoacidosis recover faster and leave the hospital sooner.

  Recruiting at 3 sites Phase 2/3 POLYSAN Scientific & Technological Pharmaceutical Company · Arkhangelsk and 2 other locations · NCT06955416

• Evaluating serum ferritin levels in patients with diabetic ketoacidosis

  This study is testing if measuring ferritin levels in adults with diabetic ketoacidosis can help predict how severe their condition is and what their short-term outcomes might be.

  Recruiting Sohag University · Sohag, Sohag Governorate · NCT06748365

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.